• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Nokia and Celesta Capital Launch Hearing Care Spinout, Astranu

by Fred Pennic 05/15/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Nokia and Celesta Capital Launch Hearing Care Spinout, Astranu

What You Should Know: 

– Nokia and Celesta Capital announced the official launch of Astranu, a new company spun out from Nokia Bell Labs. Astranu aims to transform the field of hearing care by commercializing a groundbreaking, next-generation 3D imaging technology for middle-ear conditions. 

– The venture is the first initiative under a new collaboration between Nokia and Celesta Capital designed to accelerate the market introduction of innovative technologies developed by the renowned research arm of Nokia.  

Transforming Ear Diagnostics with iOCT Technology

Astranu will leverage proprietary integrated Optical Coherence Tomography (iOCT) technology, an innovation conceived and developed at Nokia Bell Labs. This advanced technology is poised to dramatically shift ear diagnostic care by providing non-invasive, high-resolution 3D imaging of the middle ear and hearing response with unprecedented accuracy and speed.  

The core of Astranu’s offering is a highly performant yet cost-effective iOCT system. This system has the potential to address significant gaps in current healthcare practices by reducing incidences of misdiagnosis and unnecessary patient referrals. Furthermore, it aims to significantly lessen the reliance on more expensive and invasive diagnostic methods such as CT and MRI scans, or even exploratory surgery.  

Experienced Leadership to Helm Astranu

To lead the new venture, experienced healthcare technology executive Trevor Hawkins, PhD, has been appointed as CEO of Astranu. Dr. Hawkins brings decades of leadership experience in successfully scaling healthcare and diagnostic startups.  

The co-inventors of the iOCT technology, Michael Eggleston, PhD, and Bibek Samanta, PhD, who incubated and developed the technology to a state of commercial readiness at Nokia Bell Labs, will continue to support Astranu in its next phase of growth. Nokia Bell Labs will also maintain its support for Astranu by providing vital laboratory resources and ongoing R&D expertise. 

Industry Endorsement and Future Outlook

Adding further expertise to the new company, Achin Bhowmik, PhD, Chief Technology Officer and Executive Vice President of Engineering for the prominent hearing technology company Starkey, will join Astranu’s Board of Directors.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |